Valerie M Carlberg,
Locations
About
Dr. Valerie Carlberg is a board-certified dermatologist and fellowship-trained pediatric dermatologist specializing in the care of infants, children, and adolescents. She has a special interest in caring for dermatologic conditions in children with cancer as well as cancer survivors. Having trained at the Dana Farber Cancer Institute in Boston and the Seattle Cancer Care Alliance, her expertise includes the diagnosis and management of skin, hair, and nail conditions that result from chemotherapy, targeted therapy, immunotherapy, radiation, transplant, or immunosuppression. This includes graft versus host disease, reactions from medications, infections, and secondary skin cancers. Dr. Carlberg also has advanced procedural training and performs dermatologic surgery and laser surgery to treat congenital and acquired skin lesions such as melanocytic nevi (moles), cysts, vascular malformations (port wine stains), and scars. Finally, Dr. Carlberg is committed to continued education, teaching, and collaborative research to further improve the care of current and future patients.
Certifications
- Pediatric Dermatology
- Dermatology
Education
- 2013, Oregon Health & Science University, MD
Residencies
- 2017, Massachusetts General Hospital - Dermatology
- 2017, Harvard Medical School (Boston, MA) - Dermatology
Fellowships
- 2018, Seattle Children's Hospital - Pediatric Dermatology
Conditions & Treatments
Insurance Information
Ratings & Reviews
Research & Publications
Publications
Manuscripts in Refereed Journals:
Steen AJ, Mann JA, Carlberg VM, Kimball AB, Musty MJ, Simpson EL. Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients. J Am Acad Dermatol. 2017 Apr;76(4):609-617.
Chen C, Carlberg V, Kroshinsky D. Angioedema following squaric acid treatment in a 6-year-old girl. Pediatr Dermatol. Pediatr Dermatol. 2017 Jan;34(1):e44-e46.
Lee JJ, Girouard SD, Carlberg VM, Mostaghimi A. Effective Use of Mirtazapine for Refractory Pruritus Associated with Carcinoma en Cuirasse. BMJ Supportive & Palliative Care. 2016 Mar;6(1):119-21.
Sengle G, Carlberg V, Tufa SF, Charbonneau NL, Smaldone S, Carlson EJ, Ramirez F, Keene DR, Sakai LY. Abnormal Activation of BMP Signaling Causes Myopathy in Fbn2 Null Mice. PLoS Genet. 2015;11(6):e1005340.
Carlberg VM, Lofgren SM, Mann JA, Austin JP, Nolt D, Davila-Saldana B, Shereck EB, Zonana J, Krol AL. Hypohidrotic Ectodermal Dysplasia, Osteopetrosis, Lymphedema, and Immunodeficiency (OL-HED-ID) in an Infant with Multiple Opportunistic Infections. Pediatr Dermatol. 2014 Nov-Dec;31(6):716-21.
Charbonneau NL, Carlson EJ, Tufa S, Sengle G, Manalo EC, Carlberg VM, Ramirez F, Keene DR, Sakai LY. In vivo studies of mutant fibrillin-1 microfibrils. J Biol Chem. 2010; Aug 6;285(32):24943-55.
Sakai LY, Sengle G, Charbonneau NL, Carlberg VM. Extracellular regulation of growth factor signaling by fibrillin microfibrils. FASEB J. 2009;23:309.3.